Congener of CYTARABINE that is metabolized to cytarabine and thereby maintains a more constant antineoplastic action.
Also Known As:
Cyclo-C; NSC-145,668; NSC-145668; U-33,624A; U-33624A; Cyclo C; CycloC; NSC 145,668; NSC 145668; NSC145,668; NSC145668; U 33,624A; U 33624A; U33,624A; U33624A; Anhydro-Ara-C; Cyclocytidine; 6H-Furo(2',3':4,5)oxazolo(3,2-a)pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, (2R-(2alpha,3beta,3abeta,9abeta))-
Networked: 32 relevant articles (4 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Related Diseases

1. Leukemia
2. Neoplasms (Cancer)
3. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
4. Infection
5. Encephalitis (Encephalitis, Rasmussen)

Related Drugs and Biologics

1. Ancitabine
2. Cytarabine (Cytosar-U)
3. Daunorubicin (Cerubidine)
4. Prednisolone (Predate)
5. Amsacrine (AMSA)
6. Cytostatic Agents
7. Ganciclovir (Cytovene)
8. Azacitidine (5 Azacytidine)
9. pyrimidine
10. fazarabine

Related Therapies and Procedures

1. Combination Drug Therapy (Combination Chemotherapy)
2. Intravenous Infusions
3. Intraperitoneal Injections